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Prokineticin 2, a cysteine-rich secreted protein, regulates
diverse biological functions including the neurogenesis of olfac-
tory bulb. Here we show that the PK2 gene is a functional target
gene of proneural basic helix-loop-helix (bHLH) factors. Neuro-
genin 1 and MASH1 activate PK2 transcription by binding to
E-box motifs on the PK2 promoter with the same set of E-boxes
critical for another pair of bHLH factors, CLOCK and BMAL1,
in the regulation of circadian clock. Our results establish PK2 as
a common functional target gene for different bHLH transcrip-
tional factors in mediating their respective functions.
The olfactory bulb (OB)3 is one of the few structures that
have a continuous supply of newly generated neuron in the
adult brain (1, 2). Neuroprogenitor cells arise from the stem
cells located in the anterior subventricular zone of the lateral
ventricle (3, 4) and migrate tangentially as homotypic cell
chains, using each other as their migration substrate, into the
OB (5, 6), where they differentiate into inhibitory interneurons
in the granule cell layer (GCL) and periglomerular layer (PGL)
(7).
A set of proneural genes encoding the bHLH transcription
factor family is crucial for the development of vertebrate and
invertebrate nervous systems (8, 9). These bHLH factors exert
their functions by binding to E-box motifs (CANNTG) on the
promoters of their target genes (9). During development, pro-
neural bHLH factors such as Neurogenin 1(Ngn1) andMASH1
regulate several important neural developmental stages,
including the commitment of stem cells to neuronal and glial
lineages (10, 11), the specification of neuronal subtype identi-
ties (12, 13), and neuronal migration (14, 15).
Prokineticin 2 (PK2) regulates various biological functions,
including angiogenesis (16, 17), circadian rhythm (18), and
neurogenesis in the adult OB (19) via the activation of two cog-
nate G-protein-coupled receptors (20). In the adult mouse
brain, PK2 is expressed abundantly in the suprachiasmatic
nucleus (SCN) and the GCL and PGL in the OB (18, 19, 21). In
the SCN, a heterodimer of CLOCK and BMAL1, two bHLH
factors, regulates the rhythmic expression of the PK2 gene by
binding to E-box elements on the PK2 promoter (18). PK2
expression in the SCN is abolished in Clock/ and Bmal1/
mice (18), supporting the role of PK2 in regulating circadian
rhythm as a target gene of CLOCK and BMAL1. However, the
transcriptional regulation of the PK2 gene in the OB remains
unknown. The abnormal OB development in PK2-deficient
mice (19) and normal OB in Clock/ and Bmal1/mice (22,
23) indicates that PK2 is likely under the control of bHLH fac-
tors other than CLOCK and BMAL1 in the OB.
In this study, we examine the regulation of the PK2 gene by the
proneural bHLH factors Ngn1 andMASH1 in the embryonic and
postnatalmouseOB.We found that the expressionsof these genes
overlap in several populations of OB neurons, and the expression
of the PK2 gene is reduced in Ngn1 and MASH1 mutant mice.
Both Ngn1 and MASH1 positively regulate the PK2 gene tran-
scription by binding to E-boxmotifs on the PK2 promoter.More-
over, both PK2 andNgn1mutantmice have similar defects in OB
development.Our results indicate thatPK2 is a target gene of pro-
neural factors for neurogenesis in the OB.
EXPERIMENTAL PROCEDURES
Animals and Histological Examination—Postnatal and adult
mice were perfused with saline and 4% paraformaldehyde
(PFA) under anesthesia. For the embryos, the day on which the
vaginal plug was found was counted as embryonic (E) day 0.5.
E13.5–E18.5 embryos were collected from pregnant mice by
cesarean section. Embryos older than E15.5 were perfused
transcardially. Cresyl violet staining on cryosections was car-
ried out for histological examination. All procedures regarding
the care and use of animals were in accordance with institu-
tional guidelines.
In Situ Hybridization—Riboprobes for PK2, Ngn1, and
Mash1 were labeled with 35S-UTP or digoxigenin (DIG)-UTP.
In situ hybridization was performed on cryosections as
described (18, 24). Relative density of hybridization signals
using 35S-labeled probes were analyzed with ImageJ fromNIH.
Immunohistochemistry—Cryosections were blocked with
10% horse serum and incubated with primary antibody at 4 °C
overnight. Fluorescent secondary antibodies (Jackson Immu-
noResearch Laboratories, 1:200)were added subsequently. Sec-
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Supplemental Material can be found at: 
tions were counterstained with 4,6-diamidino-2-phenylindole
and viewed with a Zeiss fluorescence microscope.
Antibody used are: mouse anti-tyrosine hydroxylase (Novus
Biologicals, 1:1000), rabbit anti-MASH1 (Chemicon, 1:100),
mouse anti-Tuj1 (Covance, 1:200), rabbit anti-Ngn1 (gift from
Michael Greenberg, 1:500). The specificity of Ngn1 antibody
was tested by immunostaining on Ngn1/ tissues.
Combo Immunostaining with in Situ Hybridization—In situ
hybridization was performed with a DIG-labeled probe. Sec-
tions were then incubated in hydrogen peroxide to quench
endogenous peroxidase activity, blocked in 10% horse serum,
and incubatedwith an horseradish peroxidase-conjugated anti-
DIG antibody (PerkinElmer Life Sciences, 1:500) at 4 °C over-
night. PK2-expressing cells were revealed with the TSA Plus
fluorescence kit (PerkinElmer Life Sciences). The sections were
then immunostained and viewed under a confocal microscope.
Luciferase Reporter Assay—HEK293 cells were plated in
12-well plates at 2  105 cells/well and transfected with Lipo-
fectamine (Invitrogen). In all transfection assays, 100 ng of pro-
moter constructs were used with 300 ng of expression con-
structs of Ngn1, MASH1, p300, or CBP. Cells were harvested
after 36 h and analyzed for luciferase activity. Relative promoter
activity was calculated as described (25).
Chromatin Immunoprecipitation (ChIP)—ChIP assay was
performed using an EZ-ChIP kit (Upstate Biotechnology) follow-
ing the provided instructions. Tissues from wild-type (WT) or
mutant mice were minced with scalpels, fixed in 1% PFA at room
temperature for 15 min, and homogenized. Chromatin was
released by SDS lysis buffer and sonicated to fragments ranging
from200 to 1000 bp.Antibodies againstMASH1,Ngn1, andRNA
polymerase II were used for immunoprecipitation. Negative con-
trols were performed with nonspecific IgG antibody, no DNA
input, and tissues from Ngn1/ and Mash1/ mice. Primers
used for PCR are as follows: E-box 1, 5-TCTCAGCCTCG-
GATACTTCAC-3 and 5-GTTTCACCTTCCCACTCCTG-3;
E-box 2, 5-CTTGCCCTTTGCTTGTTTGTCTG-3 and




In Vitro Differentiation of Neural Stem Cell—Neural stem
cells were isolated from the anterior subventricular zone of
adult mice as described (26) and maintained as neurosphere in
serum-free Neurobasal-A medium supplemented with B27
(Invitrogen) and 20 ng/ml EGF. Neurospheres were dissociated
into single cells with trypsin and plated on poly-D-lysine-coated
chamber slides (NalgeNunc) at 20,000 cell/cm2.Differentiation
were induced by replacing the EGFmediumwithmedium con-
taining 0.5% fetal bovine serum with PK2 or retinoid acid. Cul-
ture media were replaced every other day. The cells were fixed
in 4% PFA for 15 min and immunostained after culture.
Neurosphere Assay—Neural stem cells were plated in
uncoated 96-well plates at 200 cell/well in Neurobasal-A
medium supplemented with different combinations of B27,
PK2, and EGF. Neurospheres were allowed to grow and
counted after 7 days.
RESULTS ANDDISCUSSION
To test the hypothesis that proneural bHLH factors regulate
PK2 gene expression in theOB, we first examined the expressions
of these genes in the OB of embryonic and postnatal mice. In situ
hybridizationwithDIG-labeled antisense probe revealed thatPK2
was expressed in the ependymal and subependymal layers of the
olfactory ventricle at E13. In postnatal day 0 (P0) and adult mice,
PK2was expressed in the GCL, the PGL, as well as the mitral cell
layer (MCL) (Fig. 1). Interestingly, similar expression patterns of
Ngn1 andMash1 were observed in the OB of E13, P0, and adult
mice (Fig. 1 and supplemental Figs. 1 and 2; sense probes showed
no hybridization signals, data not shown). The expression of PK2,
Ngn1, and Mash1 thus overlapped in several populations of OB
neurons. Immunostaining against Ngn1 and in situ hybridization
with DIG-labeled PK2 probe showed that they were co-expressed
in some neurons in theOB of adult and P0mice. Similar co-local-
izationwas also observed forMASH1 andPK2 (Fig. 1, J andK, and
data not shown).
We then examined whether Ngn1 and MASH1 could acti-
vate the PK2 promoter. As shown with luciferase reporter
assays in HEK293 cells, heterologous expression of Ngn1 acti-
vated the PK2 promoter moderately. A stronger activation was
FIGURE 1.bHLH factors andPK2 expression in theOB.A–I, in situhybridiza-
tion analysis of PK2, Ngn1, and Mash1 expression in the OB of E13 (A–C), P0
(D–F), and adult (G–I) mice. Expressions of PK2, Ngn1, andMash1 overlapped
in several populations of the neurons in the OB. Scale bar  100 m. OV,
olfactory ventricle. GL, glomerular layer. J, co-localization of Ngn1 (red) and
PK2 (green) in neurons of the adult OB. K, co-localization of MASH1 (red) and
PK2 (green) in neurons of the adult OB. Scale bar 15 m.
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produced upon the addition of CBP or p300, two transcrip-
tional coactivators of Ngn1 (11) (Fig. 2A). A construct contain-
ing the proximal E-box of the PK2 promoter could also be
transactivated by Ngn1, with or without CBP and p300,
whereas mutation of the E-box abolished the activation (Fig.
2B). Comparable with Ngn1, heterologous expression of
MASH1 also transactivated the PK2 promoter, with moderate
enhancement by CBP and p300 (Fig. 2,A and B). Importantly, a
ChIP assay confirmed the associa-
tion of Ngn1 and MASH1 with the
E-box motifs on the PK2 promoter
in vivo in theOB (Fig. 2,C–E). These
data suggested that Ngn1 and
MASH1 could regulate the expres-
sion of the PK2 gene by binding the
E-boxes on its promoter.
We further studied the regulation
ofNgn1andMASH1onthePK2gene
by examining the expression of the
PK2 gene in the OB of Ngn1/ and
Mash1/mice. In situhybridization
with 35S-labeled probe showed that
the expression of the PK2 gene in the
OB of P0Ngn1/mice was reduced
to about 30% of the level inWT con-
trols (Fig. 3A,p 0.001,n 4). In the
OB of E16.5 Mash1/ mice, the
expression of the PK2 gene was
decreased to about 50% of WT con-
trols (Fig. 3B, p 0.01, n 3). These
results indicated that both Ngn1 and
MASH1are critical for the expression
of thePK2gene in theOBand that the
residue expression of the PK2 gene in
Ngn1/ or Mash1/ mice might
result from redundant activation of
PK2 promoter by the other transcrip-
tion factor.
We have previously shown that
PK2 functions as a chemoattractant
for the migration of the progenitors for OB interneurons in
adult mice (19). As PK2 has also been shown to promote the
differentiation of hematopoietic stem cells (17, 27), we exam-
ined whether exogenous PK2 could affect the differentiation of
neural stem cell.When cultured at lowdensity (200 cells/well in
a 96-well plate) in serum-free medium supplemented with 50
nM PK2, neural progenitors from the SVZ of adult mouse did
not form neurosphere, indicating that PK2 cannot promote the
self-renewal and proliferation of neurosphere-forming cells
(Fig. 4,A andD). In addition to that, there was a great reduction
in the number of neurospheres formed when PK2 was added to
the medium with EGF (20 ng/ml) (Fig. 4D, 96  13 neuro-
spheres/well in mediumwith EGF versus 35 3 neurospheres/
well in medium with EGF and PK2). Moreover, most of the
neurospheres formed when PK2 was presented were much
smaller than the control group (Fig. 4, B, C, and E). These data
suggested that PK2 could antagonize the effect of the mitogen
and induce neural progenitors to exit the proliferation state.
Interestingly, we saw that many progenitors stopped dividing
after the first round division and thus resulted in pairs of sister
cells when only PK2 was added to the medium (Fig. 4A).
We then examined the fate of the newly generated cells by in
vitro differentiation assay. After 7 days of culture, the percent-
age of-tubulin III (Tuj1)-positive cells, amarker for immature
neurons, nearly doubled from 3.6 to 6.5% and 6.8% when 10 or
50 nM PK2 was added to the medium, comparable with the
FIGURE 3. Reduced PK2 expression in the OB of Ngn1/ and Mash1/
mice. A, 35S-labeled in situ hybridization of PK2 expression in the OB of P0WT
andNgn1/mice and quantification of PK2 signals. **, p 0.01, t test, n 4.
Scale bar 1mm. B, 35S-labeled in situ hybridization of PK2 expression in the
OB of E16.5 WT andMash1/mice and quantification of PK2 signals. **, p
0.01, t test, n 3.
FIGURE 2.Ngn1andMASH1activatePK2 expressionbybinding to E-boxes onPK2promoter.A, luciferase
(Luc) reporter assay of 2.8-kb PK2 promoter construct in HEK293 cells. Each assay was analyzed in triplicate.
E1–E4 stand for four E-boxes on the PK2promoter. B, luciferase reporter assay ofwild-type 0.2-kb PK2promoter
construct and mutant E-box construct in HEK293 cells. C, a ChIP assay showed that Ngn1 associated with E1
motif in the WT P0 mice brain but not the Ngn1/ mice. D, ChIP analyses demonstrated the association of
Ngn1, MASH1, and RNA polymerase II (Pol II) with the E1motif in the OB of adultmice. E, ChIP analyses showed
MASH1 associated with the E1 motif in the WT E16 mice brain but not theMash1/mice.
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neurogenic effect of 1M retinoid acid (Fig. 4F). After 14 days of
culture, the percentage of mature neurons (using MAP2ab as
marker) increased substantially when PK2 was added to the
medium (Fig. 4G). Taken together, our studies indicated that
PK2 could enhance the differentiation of neural progenitors
into neurons.
Deficiency of the PK2 gene leads to an abnormal OB architec-
ture in adult mice, particularly the GCL and PGL (19). Examina-
tion of the development of OB in prenatal PK2/mice showed
evidently smallerOBs at E16 andE18when comparedwith that of
WT embryos (supplemental Fig. 3). Cresyl violet staining of the
OB of P0 PK2/ mice revealed a reduction of the GCL and an
abnormalMCL.The reductionof theOB size inPK2/micewas
slightlymore severe than that ofNgn1/mice (supplemental Fig.
3) andMash1/mice (28) (datanot shown).We further analyzed
one population of PGL interneurons in PK2/ and Ngn1/
mice. Alterations in the development of the tyrosine hydroxylase
(TH)-positive interneurons were
observed in the OB of both PK2/
andNgn1/mice at P0. In theOBof
Ngn1/ mice, many TH-positive
cells did not reach their destination in
the PGL, but instead, were stalled in
the GCL, demonstrating a defect in
the migration of these interneurons.
However, in the OB of PK2/mice,
almost all TH-positive cells were
stalled in the GCL, demonstrating a
more severe defect in their migration
(Fig. 5). The relatively moderate
migration defect of TH-positive
interneurons inNgn1/micemight
result from the residue expression of
PK2 in the OB, which could still
attract some of the interneurons into
the PGL. The diminished expression
of the PK2 gene in Ngn1/ and
Mash1/miceandsimilardefects in
OB interneurons in the mutant mice
implied thatPK2 is a downstreamtar-
get gene of Ngn1 and MASH1 in the
development of the OB.
Proneural bHLH factors are piv-
otal regulators of the development
of nervous system. The known tar-
get genes of bHLH factors, most of
which are transcription factors, act
in cascades to regulate the prolifer-
ation, cell type determination, and
differentiation of neural progeni-
tors, as well as themigration of neu-
rons to their destination (8, 9). A
recent study finds that proneural
bHLH factors enhance the radial
migration of cortical neurons by
regulating the expressions of RhoA,
Dcx, and p35, genes critical for the
intrinsic cell migration machinery
(14). In this study, we provided evidence that PK2, a ligand for
G-protein-coupled receptors, is a functional target gene of
Ngn1 andMASH1.Our finding implied thatNgn1 andMASH1
can also regulate the migration of olfactory interneurons by
controlling the production of PK2, a chemoattractant secreted
by OB neurons. This is a novel mechanism that has not been
reported previously, suggesting that proneural bHLH factors
can regulate cell migration by controlling extracellular signal-
ing in addition to intrinsic migration machinery.
In addition to functioning as a chemoattractant for the migra-
tionofOB interneuronprogenitors,we found thatPK2can induce
neural progenitors to exit proliferation and promote their differ-
entiation into neurons. The expression of PK2 in the olfactory
ventricle atE13,when thegenerationofmitral cellspeaks, suggests
that PK2might also be involved in the development ofmitral cells.
Indeed,we observed an abnormalMCL in theOBofPK2/mice
(supplemental Fig. 3).A further studyof thedefectofmitral cells in
FIGURE 4. PK2 promotes the neuronal differentiation of neural progenitors. A–C, images of the neuro-
spheres formed after 7 days of culture under different conditions. Scale bar 20 m. D, quantification of the
neurospheres formedunder different conditions. *,p 0.01, t test,n 24.NBA, Neurobasal-A. E, analysis of the
size of the neurospheres formed inmediumwith or without PK2. Most of the neurospheres formedwhen PK2
was present weremuch smaller than control group. 50 nM PK2 and 20 ng/ml EGFwere used in all neurosphere
assays. F, PK2 enhanced the differentiation of neural progenitors into Tuj1-positive cells after 7 days of culture.
FBS, fetal bovine serum; RA, retinoid acid. *, p  0.01, n  3. G, PK2 enhanced the differentiation of neural
progenitors into MAP2ab-positive cells after 14 days of culture. *, p 0.01, n 3.
ACCELERATED PUBLICATION: PK2 Is a Target Gene of bHLH Factors
















the OB of PK2/mice would shed light on the effect of PK2 on
mitral cell development. Taken together, our data suggest that
PK2, as a functional target gene, appears tomediate some roles of
Ngn1 andMASH1 in the OB neurogenesis.
Previously, we have demonstrated that PK2 gene is a func-
tional target of another pair of bHLH factors, CLOCK and
BMAL1, in the regulation of mammalian circadian clock (18).
Intriguingly, the same set of E-boxes on the PK2 promoter
appears to be utilized by both groups of bHLH factors. It has
also been suggested that PK2 expressionmight be controlled by
hypoxia-inducible factor 1, another bHLH factor and key
mediator for angiogenesis under hypoxia conditions (16). Our
results thus establish PK2 as a common functional target gene
for different bHLH factors in regulating their respective func-
tions (supplemental Fig. 4). Our studies also provide an exam-
ple that the complexity of mammalian genome is probably not
due to a sheer increase in the quantity of genes butmost likely to
complicated gene regulation networks (29).
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